6 Analysts Have This to Say About Immunogen
December 30, 2022 at 11:01 AM EST
Over the past 3 months, 6 analysts have published their opinion on Immunogen (NASDAQ:IMGN) stock. These analysts are typically employed ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.